Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values
- PMID: 23584902
- DOI: 10.1002/lt.23649
Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values
Abstract
Portopulmonary hypertension (POPH), a complication of chronic liver disease, may be a contraindication to liver transplantation (LT) because of the elevated risk of peritransplant and posttransplant morbidity and mortality. Because POPH is frequently asymptomatic, screening with echocardiography is recommended. The only reliable technique, however, for diagnosing POPH is right heart catheterization (RHC). The aims of this study were to evaluate the current estimated systolic pulmonary artery pressure (sPAP) cutoff value of 30 mm Hg and to determine a better cutoff value. One hundred fifty-two patients underwent pretransplant echocardiography between January 2005 and December 2010. These echocardiographic results were compared with pulmonary artery pressures measured during the pretransplant workup or at the beginning of the transplantation procedure (both by catheterization). With a cutoff value of 30 mm Hg, 74 of the 152 patients met the criteria for POPH on echocardiography, although the diagnosis was confirmed in only 7 patients during catheterization; this resulted in a specificity of 54%. It would have been more accurate to use a cutoff value of 38 mm Hg, which had a maximal specificity of 82% and, at the same time, guaranteed a sensitivity and negative predictive value of 100%. With the incorporation of the presence or absence of right ventricular dilatation, the specificity even increased to 93% for this new cutoff value. In conclusion, the prevalence of POPH was 4.6% among LT candidates in this study. We can recommend that LT candidates with an sPAP > 38 mm Hg should be referred for RHC. With the cutoff value increased from 30 to 38 mm Hg, the number of patients undergoing invasive RHC during their evaluation could be safely reduced.
Copyright © 2013 American Association for the Study of Liver Diseases.
Comment in
-
Transthoracic echocardiography screening for the detection of portopulmonary hypertension: a work in progress.Liver Transpl. 2013 Jun;19(6):573-4. doi: 10.1002/lt.23663. Liver Transpl. 2013. PMID: 23716426 No abstract available.
Similar articles
-
Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates.Clin Transplant. 2019 Jul;33(7):e13585. doi: 10.1111/ctr.13585. Epub 2019 Jun 5. Clin Transplant. 2019. PMID: 31074522
-
Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta-analysis.Clin Transplant. 2020 Nov;34(11):e13995. doi: 10.1111/ctr.13995. Epub 2020 Sep 27. Clin Transplant. 2020. PMID: 32485008
-
Portopulmonary hypertension: Results from a 10-year screening algorithm.Hepatology. 2006 Dec;44(6):1502-10. doi: 10.1002/hep.21431. Hepatology. 2006. PMID: 17133488
-
Portopulmonary hypertension: an update.Liver Transpl. 2012 Aug;18(8):881-91. doi: 10.1002/lt.23485. Liver Transpl. 2012. PMID: 22674534 Review.
-
Portopulmonary hypertension.Clin Liver Dis. 2014 May;18(2):421-38. doi: 10.1016/j.cld.2014.01.004. Epub 2014 Feb 25. Clin Liver Dis. 2014. PMID: 24679504 Review.
Cited by
-
Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis.Int J Gen Med. 2022 Jan 25;15:859-865. doi: 10.2147/IJGM.S339474. eCollection 2022. Int J Gen Med. 2022. PMID: 35115812 Free PMC article.
-
Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study.J Am Heart Assoc. 2024 Apr 16;13(8):e033847. doi: 10.1161/JAHA.123.033847. Epub 2024 Apr 3. J Am Heart Assoc. 2024. PMID: 38567662 Free PMC article.
-
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) Exceptions.Transplant Direct. 2025 Feb 7;11(3):e1757. doi: 10.1097/TXD.0000000000001757. eCollection 2025 Mar. Transplant Direct. 2025. PMID: 39936134 Free PMC article.
-
The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.Clin Gastroenterol Hepatol. 2015 Nov;13(12):2118-27. doi: 10.1016/j.cgh.2015.04.024. Epub 2015 Apr 28. Clin Gastroenterol Hepatol. 2015. PMID: 25934564 Free PMC article. Review.
-
Portopulmonary hypertension: Current developments and future perspectives.Liver Res. 2022 Mar 3;6(1):10-20. doi: 10.1016/j.livres.2022.02.002. eCollection 2022 Mar. Liver Res. 2022. PMID: 39959808 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous